Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • A Phase 4 Study of Crizanlizumab Treatment for Patients with Sickle Cell Disease Who Previously Participated in Novartis Clinical Trials

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy Spain
  • Study on Baxdrostat for Lowering Blood Pressure in Patients with Resistant Hypertension

    Not recruiting

    1 1
    Investigated drugs:
    Belgium Bulgaria Czechia Germany Greece Hungary +3
  • Study on Axatilimab for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    Investigated drugs:
    Belgium Czechia France Germany Italy Poland +2
  • Study on Dexlansoprazole for Treating and Maintaining Healing of Erosive Esophagitis in Children Aged 2 to 11 Years

    Not recruiting

    1 1
    Investigated drugs:
    Poland
  • Study on the Long-term Effects of Methylone for Treating PTSD in Patients

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Ireland
  • Study of Tamibarotene, Venetoclax, and Azacitidine for Adults with RARA-positive Acute Myeloid Leukemia Not Eligible for Standard Therapy

    Not recruiting

    1 1 1
    Investigated diseases:
    France
  • Study on the Safety and Effectiveness of Dexlansoprazole for Treating Nonerosive GERD in Children Aged 2 to 11 Years

    Not recruiting

    1 1
    Investigated drugs:
    Poland
  • Study on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Moderate-to-Severe Plaque Psoriasis

    Not recruiting

    1 1
    Investigated drugs:
    Czechia Finland France Germany Hungary Poland +2
  • Study on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment

    Not recruiting

    1 1 1 1
    Belgium Czechia France Germany Italy The Netherlands +3
  • Study Comparing Pralsetinib and Standard Drug Combination for Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1 1
    Belgium France Germany Ireland Italy The Netherlands +4